AI-generated summary
The authors report a small crossover trial of 22 healthy volunteers who received photobiomodulation with an 810 nm laser at two energy doses or a sham treatment, with endothelial function measured by flow-mediated dilation before and after. The study found no statistically significant difference between the active doses and placebo, and the authors concluded that the 30 J and 60 J doses did not improve endothelial function.
- Participants
- 22
- Who or what was studied
- Healthy adult volunteers, mostly female (77.3%), average age about 25
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The abstract describes the trial as preliminary with a small sample of 22 healthy volunteers, and the reported percentage changes and mean differences do not establish a clear treatment effect.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Energy density (fluence)
- 107 J/cm2, 214 J/cm2
- Power
- 1000 mW
- Total energy
- 30 J, 60 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Effect size, Trial registration, Laser, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.